Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dwight Hall Owen"'
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 18(1)
Autor:
Dwight Hall Owen, Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou, Sheryl-Ann Suffren, Carly Pilcher, Gwen Christenson, Nancy Curtis, Himanshu Savardekar, Ruthann Norman, Sarah Ferguson, Barbara Kleiber, Robert Wesolowski, William Edgar Carson, Gregory Alan Otterson, Claire F. Verschraegen, Manisha H. Shah, Bhavana Konda
Publikováno v:
Journal of Clinical Oncology. 40:4121-4121
4121 Background: Treatment options are limited in patients with metastatic NEN. Temozolomide (TEM) alone and in combination with capecitabine is active in NEN and has been shown to have immunomodulatory impact. Here we present the final results for t
Autor:
Vineeth Sukrithan, Brooke Benner, Lai Wei, Ashima Goyal, Ye Zhou, Sheryl-Ann Suffren, Carly Pilcher, Gwen Christenson, Nancy Curtis, Emily Schwarz, Himanshu Savardekar, Ruthann Norman, Barbara Kleiber, Robert Wesolowski, Gregory Alan Otterson, Claire F. Verschraegen, William Edgar Carson, Manisha H. Shah, Bhavana Konda, Dwight Hall Owen
Publikováno v:
Journal of Clinical Oncology. 40:4123-4123
4123 Background: LAG-3 is an immune checkpoint present on NK cells, activated T cells and myeloid cells that inhibit T cell responses. Recent evidence demonstrating the safety and efficacy of LAG-3 inhibition has increased interest in this pathway fo
Autor:
Angel Qin, Daniel Morgensztern, Saiama Naheed Waqar, Dwight Hall Owen, Shirish M. Gadgeel, Gregory Peter Kalemkerian, Lili Zhao, Nithya Ramnath
Publikováno v:
Journal of Clinical Oncology. 40:TPS9138-TPS9138
TPS9138 Background: Carboplatin, pemetrexed, and pembrolizumab (CPP) followed by pemetrexed and pembrolizumab maintenance is a standard of care (SOC) for non-squamous metastatic non-small cell lung cancer (NSCLC), based on results of the KEYNOTE-189